Search Results 261-270 of 16928 for Adipokine

  1. Safety, Tolerability And Pharmacodynamic Activity Of Sotagliflozin In Hemodynamically Stable Patients With Worsening Heart Failure - Mayo Clinic

    Secondary Objectives: - Explore the effect of sotagliflozin on erythropoiesis, as assessed by changes in plasma erythropoietin levels, in hemodynamically stable ...

  2. Understanding the Genetic and Molecular Basis of Lipodystrophy - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Study To Determine The Effectiveness And Safety Of Dupilumab In Adult And Adolescent Patients With Eosinophilic Esophagitis (EoE) - Mayo Clinic

    Part B: To demonstrate the efficacy of dupilumab treatment compared with placebo in adult and adolescent patients with EoE after 24 weeks of treatment as ...

  4. Clinical trials - Gastroenterology and Hepatology

    In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the Investigator's ...

  5. Study To Identify Allergen Epitopes In Individuals With Peanut Allergy - Mayo Clinic

    The purpose of this study is to use samples from multiple patients to validate and provide detailed mapping of food to identify allergen epitopes. This will ...

  6. Hematology - Clinical trials

    Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.

  7. Digestive Diseases Clinical Trials - Medical Professionals

    Rochester, Minn. This is a survey study to describe how women with Lynch syndrome are being screened for gynecologic cancer risk, their perception of cancer ...

  8. News - William A. Faubion, Jr., M.D. - Mayo Clinic

    William A. Faubion, Jr., M.D. · News · National Doctors' Day is March 30! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers.

  9. OCEAN(a)-PreEvent - Olpasiran Trials Of Cardiovascular Events And LipoproteiN(a) Reduction To Prevent First Major Cardiovascular Events - Mayo Clinic

    The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial ...

  10. Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, ...